ORKA

JANUS HENDERSON GROUP PLC

Known title: 10% OwnerCIK: 0001274173

JANUS HENDERSON GROUP PLC's purchase track record

How the stock did after each of JANUS HENDERSON GROUP PLC's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
4
of 4 since July 3, 2024
Stock higher 6 months later
0%
3 months: 100%
Median 6-month return
-32.1%
3 months: +23.8%
Beat the S&P 500
0%
median -40.3% vs. index
PurchaseStockAmount3 months6 months
8/16/2024ORKA$17K+26.3%-41.3%
7/24/2024ORKA$699K+49.9%-37.5%
7/11/2024ORKA$326K+21.3%-26.6%
7/3/2024ORKA$1.10M+11.6%-10.8%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 7, 2026

HC Wainwright Reiterates $120 Target on Oruka. HC Wainwright maintained its buy rating on Oruka Therapeutics, keeping its price target at $120. The firm continues to see the company favorably despite recent trading levels well below that target. The analyst consensus average for the stock stands at $153.75, with estimates ranging from $102 to $200.

this person other insiders at ORKA

Transaction History

ORKA▲ Buy$16K
ORKA▲ Buy$1K
ORKA▲ Buy$92K
ORKA▲ Buy$528K
ORKA▲ Buy$57K
ORKA▲ Buy$22K
ORKA▲ Buy$326K
ORKA▲ Buy$116K
ORKA▲ Buy$76K
ORKA▲ Buy$58K
ORKA▲ Buy$102K
ORKA▲ Buy$62K
ORKA▲ Buy$17K
ORKA▲ Buy$80K
ORKA▲ Buy$590K

We use analytics to understand how market-wall is used. No personal data is sold.